Cargando…

Corrigendum: Peptide-based vaccine for cancer therapies

Detalles Bibliográficos
Autores principales:	Buonaguro, Luigi, Tagliamonte, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641211/ https://www.ncbi.nlm.nih.gov/pubmed/37965343 http://dx.doi.org/10.3389/fimmu.2023.1324894

Ejemplares similares

Peptide-based vaccine for cancer therapies
por: Buonaguro, Luigi, et al.
Publicado: (2023)

Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2020)

Selecting Target Antigens for Cancer Vaccine Development
por: Buonaguro, Luigi, et al.
Publicado: (2020)

MHC-Optimized Peptide Scaffold for Improved Antigen Presentation and Anti-Tumor Response
por: Tagliamonte, Maria, et al.
Publicado: (2021)

HLA Does Not Impact on Short-Medium-Term Antibody Response to Preventive Anti-SARS-Cov-2 Vaccine
por: Ragone, Concetta, et al.
Publicado: (2021)

Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
por: Tornesello, Anna Lucia, et al.
Publicado: (2022)

Systems Biology Approach for Cancer Vaccine Development and Evaluation
por: Circelli, Luisa, et al.
Publicado: (2015)

Molecular mimicry and cancer vaccine development
por: Tagliamonte, Maria, et al.
Publicado: (2023)

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response
por: Tagliamonte, Maria, et al.
Publicado: (2022)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Prediction of individual immune responsiveness to a candidate vaccine by a systems vaccinology approach
por: Petrizzo, Annacarmen, et al.
Publicado: (2014)

Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients
por: Hernandez, Susana Patricia Amaya, et al.
Publicado: (2023)

Identification and validation of viral antigens sharing sequence and structural homology with tumor-associated antigens (TAAs).
por: Ragone, Concetta, et al.
Publicado: (2021)

Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example
por: Buonaguro, Luigi, et al.
Publicado: (2007)

Conformational HIV-1 Envelope on particulate structures: a tool for chemokine coreceptor binding studies
por: Tagliamonte, Maria, et al.
Publicado: (2011)

Editorial: Novel Strategies for Anti-Tumor Vaccines
por: Accolla, Roberto S., et al.
Publicado: (2020)

Long-term memory T cells as preventive anticancer immunity elicited by TuA-derived heteroclitic peptides
por: Mauriello, Angela, et al.
Publicado: (2021)

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
por: Stephens, Alexander J., et al.
Publicado: (2021)

Effects of adjuvants on IgG subclasses elicited by virus-like Particles
por: Visciano, Maria Luisa, et al.
Publicado: (2012)

Cell Surface Proteins in Hepatocellular Carcinoma: From Bench to Bedside
por: Siracusano, Gabriel, et al.
Publicado: (2020)

Peptide-Based Vaccines for Tuberculosis
por: Gong, Wenping, et al.
Publicado: (2022)

New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology
por: Tornesello, Anna Lucia, et al.
Publicado: (2017)

Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Corrigendum: In silico Design of an Epitope-Based Vaccine Ensemble for Chagas Disease
por: Michel-Todó, Lucas, et al.
Publicado: (2020)

Corrigendum: Mind the “vaccine fatigue”
por: Su, Zhaohui, et al.
Publicado: (2023)

Corrigendum: Elucidation of the Signatures of Proteasome-Catalysed Peptide Splicing
por: Paes, Wayne, et al.
Publicado: (2021)

Potential association factors for developing effective peptide-based cancer vaccines
por: Jiang, Chongming, et al.
Publicado: (2022)

Corrigendum: Vaccines Against Antimicrobial Resistance
por: Rosini, Roberto, et al.
Publicado: (2020)

Human Endogenous Retrovirus Reactivation: Implications for Cancer Immunotherapy
por: Petrizzo, Annacarmen, et al.
Publicado: (2021)

Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
por: Petrizzo, Annacarmen, et al.
Publicado: (2017)

Corrigendum: Integration: gospel for immune bioinformatician on epitope-based therapy
por: Sun, Baozeng, et al.
Publicado: (2023)

Present status and future perspective of peptide‐based vaccine therapy for urological cancer
por: Obara, Wataru, et al.
Publicado: (2018)

Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies
por: Klausen, Uffe, et al.
Publicado: (2018)

Neoantigens as potential vaccines in hepatocellular carcinoma
por: Repáraz, David, et al.
Publicado: (2022)

Peptide Vaccines for Leishmaniasis
por: De Brito, Rory C. F., et al.
Publicado: (2018)

Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine
por: Feola, Sara, et al.
Publicado: (2022)

Molecular mimicry between tumor associated antigens and microbiota-derived epitopes
por: Ragone, Concetta, et al.
Publicado: (2022)

P12-03. Generation of novel recombinant HIV-1 glycoproteins for expression on virus like particles
por: Tagliamonte, M, et al.
Publicado: (2009)

HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens
por: Tagliamonte, Maria, et al.
Publicado: (2012)

Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines
por: Jiang, Shisong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7f3f9h5jfodskv7apth49f7nqr